Original Research Put Into Perspective for the Practicing Clinician Incidence, Cause, and Comparative Frequency of Sudden Cardiac Death in National Collegiate Athletic Association Athletes: A Decade in Review
Original Research Put Into Perspective for the Practicing Clinician Incidence, Cause, and Comparative Frequency of Sudden Cardiac Death in National Collegiate Athletic Association Athletes: A Decade in Review
复制标题
DOI:
--
复制
发表时间:
2015
期刊:
影响因子:
--
通讯作者:
中科院分区:
文献类型:
--
作者:
The incidence of sudden cardiac death (SCD) in young people is hotly debated. It is important to have an accurate understanding of the overall incidence in the context of other risks of death to identify groups where additional preventive strategies should be considered. This study confirms earlier findings of a higher rate of SCD in National Collegiate Athletic Association athletes (1 in 53 703) with males (1 in 37 790), blacks (1 in 21 491), and male basketball athletes (1 in 9000) at higher risk. In fact, Division I male basketball players are 5 times more likely to die of SCD than to die in a car accident. This study also demonstrates that the differences in methodology to identify cases will drastically affect results and that media reports are an unreliable way to identify SCD, in particular, in lower-profile athletes. Similarly, the use of insurance claims for case identification detected only a fraction of SCDs in athletes (1/10). This creates challenges to accurately understand the incidence of SCD in high school and youth athletes without better reporting mechanisms. This study found a higher proportion of autopsy-negative sudden unexplained death (25%) than previously described in US athletes and a lower proportion of hypertrophic cardiomyopathy (8%). Standardized autopsies and postmortem genetic testing are needed to better define the causes of SCD. National Collegiate Athletic Association athletes are currently screened at matriculation for cardiovascular disease. Concern has been expressed regarding resource use, but more intensive screening may be warranted in high-risk groups. See p 10.